Anlotinib Hydrochloride Combined With Liposomal Doxorubicin in the Treatment of Locally Advanced or Metastatic Soft Tissue Sarcoma
Condition: Sarcoma Intervention: Drug: Anlotinib+ Liposomal Doxorubicin Sponsors: Peking University People's Hospital; Peking University Shougang Hospital; Beijing Cancer Hospital; Tianjin Medical University Cancer Institute and Hospital; First Hospital of Jilin University; Hunan Cancer Hospital; Ruijin Hospital; Liaoning Tumor Hospital & Institute Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials